Pharma News & Analysis

Tuesday, May 19, 2009

Details of Pharm.D Colleges in India

click on the links below for more details

Pharm.D in Karnataka

Pharm.D in Tamilnadu

Pharm.D in Andhra Pradesh

Pharm.D in Maharastra and Madhya Pradesh
at 6:42:00 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Post Older Post Home

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments

Popular Posts

  • Funny Clinical Research Cartoons
  • MenAfriVac, meningitis vaccine administered to 100 millionth person
  • Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
  • Access to Medicine Index 2012
  • Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
  • Colleges offering Pharm.D in Andhra Pradesh
  • FDA agrees to review Merck's Suvorexant for sleeplessness
  • New drug approved by US FDA for the treatment of COPD
  • Computer Exercises May Offer New Hope for Alzheimer's Patients
  • Merck Opens New Manufacturing Facility in Hangzhou, China

Blog Archive

  • ►  2024 (1)
    • ►  March (1)
  • ►  2023 (16)
    • ►  November (2)
    • ►  October (7)
    • ►  May (7)
  • ►  2022 (13)
    • ►  September (8)
    • ►  July (3)
    • ►  June (1)
    • ►  April (1)
  • ►  2021 (24)
    • ►  November (13)
    • ►  October (8)
    • ►  September (3)
  • ►  2015 (1)
    • ►  April (1)
  • ►  2014 (4)
    • ►  January (4)
  • ►  2013 (44)
    • ►  December (20)
    • ►  November (10)
    • ►  October (2)
    • ►  September (1)
    • ►  May (3)
    • ►  April (8)
  • ►  2012 (343)
    • ►  December (2)
    • ►  November (5)
    • ►  September (112)
    • ►  August (197)
    • ►  July (5)
    • ►  April (4)
    • ►  March (10)
    • ►  February (3)
    • ►  January (5)
  • ►  2011 (121)
    • ►  December (19)
    • ►  October (9)
    • ►  September (11)
    • ►  August (30)
    • ►  June (9)
    • ►  May (8)
    • ►  April (14)
    • ►  March (11)
    • ►  February (6)
    • ►  January (4)
  • ►  2010 (105)
    • ►  December (31)
    • ►  November (10)
    • ►  August (1)
    • ►  June (7)
    • ►  April (9)
    • ►  March (4)
    • ►  February (24)
    • ►  January (19)
  • ▼  2009 (222)
    • ►  December (23)
    • ►  November (6)
    • ►  October (9)
    • ►  September (16)
    • ►  August (62)
    • ►  July (32)
    • ►  June (31)
    • ▼  May (17)
      • M. Pharm Seats in Dr. M.G.R Medical University
      • Dr. MGR University Job Fair - CATCH 2009
      • Pharmacy Faculty Jobs - Hyderabad
      • NIPER Mohali Project Walk In for MS Pharm.(Medicin...
      • Pharma News Today
      • Mr. Malvinder Mohan Singh stepped down from the po...
      • Vacancy for Pharmacopoeial Associates
      • Patent Awareness Seminar
      • Dr. M.G.R University M.Pharmacy Counselling 2009
      • Details of Pharm.D Colleges in India
      • Education, Career counselling and Job fair by Dr. ...
      • QIP 2009: M.Pharm and Ph.D
      • General Course on Intellectual Property
      • World Pharma market reports
      • Sixth National Workshop on Basic Techniques in Mo...
      • Workshop on Drug Master Files - Compilation & Comp...
      • No proper faculty in many Pharmacy colleges in India
    • ►  March (15)
    • ►  February (11)
  • ►  2008 (29)
    • ►  December (4)
    • ►  September (1)
    • ►  July (2)
    • ►  June (6)
    • ►  May (1)
    • ►  April (5)
    • ►  March (7)
    • ►  January (3)
  • ►  2007 (3)
    • ►  December (2)
    • ►  October (1)

Topics

pharma (171) regulation (82) drugs (81) Regulatory (63) News (57) Education (55) clinical (51) clinical research (49) FDA (45) clinical trials (40) conference (29) swine flu (28) DCGI (27) Approval (25) India (25) workshop (25) markets (23) admission (19) colleges (19) company news (19) patent (19) seminar (19) job (18) research (18) vacancy (15) courses (14) IPR (11) pharm.d (11) pharmacy (11) New drugs (10) vaccines (10) IPC (9) M.Pharm (9) statistics (9) training (9) CRO (8) WHO (8) cancer (8) diseases (8) government (8) Pharmacopoeia (7) oncology (7) Awards (6) NIPER (6) Pfizer (6) expo (6) healthcare (6) people (6) sales (6) BMS (5) FDC (5) GSK (5) Industry (5) NPPA (5) PCI (5) diabetes (5) exports (5) guidance (5) spurious drugs (5) DTAB (4) DoP (4) ban (4) biotech (4) career (4) certification (4) diagnostics (4) journals (4) pharmacovigilance (4) teaching (4) CDSCO (3) Devices (3) FICCI (3) GATE (3) ICMR (3) IDMA (3) Malaria (3) Novartis (3) Roche (3) articles (3) banned drugs (3) blog (3) generics (3) interview (3) job cuts (3) law (3) market research (3) policy (3) recruitment (3) technology (3) virtual clinical trials (3) AICTE (2) AIDS (2) AIIMS (2) AstraZeneca (2) Ayush (2) BCG (2) Biocon (2) CDA (2) China (2) DLBCL (2) Deal (2) Discovery (2) EMEA (2) Europe (2) GMP (2) HIV (2) Hospital (2) IMS (2) IND (2) IPA (2) Maharastra (2) Manufacturing (2) Merck (2) Ranbaxy (2) SRF (2) Sanofi (2) Strategy (2) Weight loss (2) abstacts (2) adverticle (2) biosimilars (2) chikungunya (2) counselling (2) fraud (2) funny (2) machinery (2) manipal (2) marketing (2) meeting (2) merger (2) pharmacology (2) pricing (2) project (2) side effects (2) tamilnadu (2) testing (2) treatment (2) videos (2) ACTE (1) AIPS (1) ASBMR (1) Access to Medicine (1) Africa (1) Amylin (1) Ardea (1) Arthritis (1) Atropa (1) Awareness (1) BA/BE (1) BITS Pilani (1) British (1) CBER (1) CCMB (1) CCRH (1) CEP (1) CFDA (1) CHMP (1) CII (1) COPD (1) CPHl (1) Chronic Diseases (1) ClinicalTrials.gov (1) Colchicine (1) Crowdsourcing (1) DBT (1) DCA (1) DPCO (1) DPST (1) DST (1) Dapagliflozin (1) Diabetic retinopathy (1) Diptheria (1) Drug discontinuation (1) Drug inspector (1) Elder (1) Electroceuticals (1) Events (1) FDCA (1) FGSCDA (1) FMRAI (1) Febuxostat (1) Formulary (1) GDP (1) GOBIOM (1) GPAT (1) GVK (1) Gene (1) Gout (1) H1N1 (1) HPV (1) Heart failure (1) Hepatitis (1) ICT (1) ILDS (1) IPGA (1) IPSCON (1) IRB (1) ISCR (1) Import (1) Infants (1) Influenza (1) Innocentive (1) Insomnia (1) Internet (1) Investment (1) JOVE (1) JRF (1) JnJ (1) KDPMA (1) Launch (1) Lilly (1) MBA (1) MCI (1) MHRA (1) MedImmune (1) Media (1) Medical (1) Medical Tourism (1) Medicine (1) Medicines (1) Meningitis (1) Monographs (1) Mutation (1) NDA (1) Nanomedicine (1) Neuroscience (1) OAB (1) Obesity (1) Operations (1) Osteoarthritis (1) Ozone Pharma (1) Pharma Industry (1) Pharmexcil (1) Phase IV (1) Pipeline (1) Pneumonia (1) Preclinical (1) QA (1) QIP (1) Reference (1) SMS (1) Smoking (1) Standards (1) Sun Pharma (1) TB (1) TNCDA (1) Takeda (1) Teijin (1) Tetanus (1) Thyroid (1) Tobacco (1) UGC (1) UK (1) URL pharma (1) US (1) Wyeth (1) accredition (1) adverse effects (1) albinism (1) alternative medicine (1) amgen (1) bihar (1) bill (1) biomarker (1) biopharm (1) brain fever (1) budget (1) campaign (1) cisapride (1) contest (1) counterfeit (1) court (1) cpcsea (1) cytrx (1) degree (1) delhi (1) depression (1) device (1) diet (1) draft (1) drugs control (1) economy (1) ethics (1) exam (1) faculty (1) grants (1) hyderabad (1) info (1) informed consent (1) innovation (1) inspection (1) international (1) jobs (1) karnataka (1) kerala (1) lab (1) lesinurad (1) loans (1) misconduct (1) new year (1) nimesulide (1) novo nordisk (1) nuts (1) orchid (1) osteoporosis (1) overpricing (1) parliament (1) peanuts (1) pharmacogenomics (1) phase I (1) pictures (1) pollution (1) product safety (1) profit (1) rajasthan (1) recognition (1) report (1) resistance (1) reward (1) salary (1) scholarships (1) serum institute (1) sibutramine (1) skin cancer (1) soft tissue sarcoma (1) sri lanka (1) stiefel (1) stockists (1) support (1) survey (1) symposia (1) tanzania (1) thanks (1) transplantation (1) updates (1) virus (1) what to name it (1) youtube (1)
Copyright© 2016, Pharma News & Analysis. Powered by Blogger.